Medindia LOGIN REGISTER
Medindia
Advertisement

New Research Speculates On The Rosetta Stone for Antibiotic Resistance

by Kathy Jones on October 26, 2013 at 11:07 PM
 New Research Speculates On The Rosetta Stone for Antibiotic Resistance

A novel technique to confront the problem of antibiotic resistance is published in JoVE, the Journal of Visualized Experiments.

According to Dr. Joseph Ndieyira, one of the developers involved in the technique, "The use of this technology will allow scientists to understand how antibiotics work, how bacteria develop resistance, and what molecular mechanisms could be exploited to get around their defense mechanisms."

Advertisement

"We report a novel, nanomechanical approach to investigate the workings of vancomycin ... one of the last powerful antibiotics used to combat increasingly-resistant infections such as methicillin-resistant Staphylococcus aureus (MRSA)," said Ndieyira.

Using tiny cantilevers (or beams) no wider then a human hair, Ndieyira and his colleagues take advantage of the cellular stress that antibiotics, when effective, impose on a target bacteria's cell wall. Such stress in turn causes the cantilevers to bend. Using lasers, the bending can then be measured-providing tremendous insight into the drug-target interaction.
Advertisement

According to Ndieyira, the cantilever technology confronts a growing problem of multidrug-resistant hospital superbugs. It could aid in the drug discovery process by preventing lead-drug candidates from being disregarded due to a lack of equipment with sufficient sensitivity, and its hope is to jumpstart an already stagnated drug-pipeline by providing this sensitivity in an efficient manner-the cantilever method can simultaneously measure and track a variety of drug-bacteria interactions in real time.

"The cantilever assays provide a resolution that simply cannot be obtained with conventional methods, such as those using fluorescence," said Ndieyira, "For example, cantilever sensors can resolve forces of ~10 pN, which is sensitive enough to detect the rupturing of individual hydrogen bonds." According to the article, a single hydrogen molecule can be the difference between drug-susceptible and drug-resistant bacteria.

The cantilever technique is currently under review in the science journal Nature for its clinical use in a microchip. "This prototype will provide a platform for more sensitive measurements, enabling results in early detection of infectious diseases, rapid identification of a host of new biomarkers, and for the engineering of portable diagnostic tools," said Ndieyira. He also described the technique as a possible alternative for drug experimentation on animals.

When asked why he and his colleagues decided to publish their technique through video, Ndieyira said, "JoVE is the only journal that provides a unique and powerful opportunity to communicate my latest measurements and procedures visually, thus making it easy and effective for others to replicate the experiment."

About JoVE, the Journal of Visualized Experiments:

JoVE, the Journal of Visualized Experiments, is the first and only PubMed/MEDLINE-indexed, peer-reviewed journal devoted to publishing scientific research in a video format. Using an international network of videographers, JoVE films and edits videos of researchers performing new experimental techniques at top universities, allowing students and scientists to learn them much more quickly. JoVE has published video-protocols from an international community of nearly 8,000 authors in the fields of biology, medicine, chemistry, and physics.



Source: Newswise
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

New Immunotherapy for Psoriasis & Vitiligo
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
2050 Forecast: 1.06 Billion Individuals to Face 'Other' Musculoskeletal Disorders
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Gene Therapies Can Disrupt Gaucher Disease Drug Market
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
NASH Cases Expected to Hit 26.55 Million in 7MM by 2032
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
Can Sleep Brain Waves Defend Against Epileptic Activity?
Memory deficits in individuals with epilepsy, especially cognitive difficulties, might partially stem from the transient impairments caused by these slow waves.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Research Speculates On The Rosetta Stone for Antibiotic Resistance Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests